AC Immune (ACIU) Depreciation & Amortization (CF) (2016 - 2025)
AC Immune has reported Depreciation & Amortization (CF) over the past 10 years, most recently at $411634.9 for Q4 2025.
- Quarterly Depreciation & Amortization (CF) changed 0.45% to $411634.9 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Mar 2026, down 22.42% year-over-year, with the annual reading at $1.7 million for FY2025, 2.82% up from the prior year.
- Depreciation & Amortization (CF) was $411634.9 for Q4 2025 at AC Immune, down from $425037.2 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $539118.9 in Q3 2021 and troughed at $401522.4 in Q1 2025.
- The 5-year median for Depreciation & Amortization (CF) is $452536.6 (2022), against an average of $459036.8.
- Year-over-year, Depreciation & Amortization (CF) surged 37.14% in 2021 and then dropped 15.88% in 2022.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $527068.0 in 2021, then fell by 9.01% to $479566.1 in 2022, then decreased by 1.97% to $470106.8 in 2023, then fell by 12.83% to $409806.3 in 2024, then increased by 0.45% to $411634.9 in 2025.
- Per Business Quant, the three most recent readings for ACIU's Depreciation & Amortization (CF) are $411634.9 (Q4 2025), $425037.2 (Q3 2025), and $438464.2 (Q2 2025).